Acute schizophrenia
Information
- Disease name
- Acute schizophrenia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00140166 | Completed | Phase 4 | Treatment of Acute Schizophrenia With Vitamin Therapy | July 2005 | May 2008 |
| NCT00350467 | Completed | Phase 3 | A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia | June 2006 | September 2007 |
| NCT01668797 | Completed | Phase 3 | Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia | October 2012 | February 2015 |
| NCT03160521 | Completed | Phase 3 | Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia | June 2, 2017 | December 17, 2018 |
| NCT01393613 | Completed | Phase 3 | Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia | July 2011 | February 2014 |
| NCT01396421 | Completed | Phase 3 | Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia | July 2011 | January 2014 |
| NCT01490086 | Completed | Phase 2 | RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder | December 2011 | March 2013 |
| NCT05325645 | Recruiting | Phase 3 | Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia | June 21, 2022 | May 2025 |
| NCT00838032 | Unknown status | Phase 4 | Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia | August 2008 | May 2010 |